[HTML][HTML] Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and …
M Qu, T Han, X Chen, Q Sun, Q Li… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Hepatocellular carcinoma (HCC) is one of the malignant tumors with the
highest morbidity and mortality worldwide, and its prognosis remains a challenge. Actinidia …
highest morbidity and mortality worldwide, and its prognosis remains a challenge. Actinidia …
RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study
EM Said, AA Salem, HI Shousha, ES Ahmad… - Arab Journal of …, 2022 - Elsevier
Background and study aims Chronic hepatitis B (CHB) infection is a major risk factor for
hepatocellular carcinoma (HCC). The RECK gene is a critical tumor suppressor gene. This …
hepatocellular carcinoma (HCC). The RECK gene is a critical tumor suppressor gene. This …
Evaluation of PRDM1 gene polymorphism with hepatitis C virus-related hepatocellular carcinoma in a cohort of Egyptian patients
AM Ibrahim, AA Mohamed, OE Esmail… - … and Medical Sciences, 2023 - journals.ekb.eg
AbstractThe third most common cancer-related cause of death worldwide is hepatocellular
carcinoma (HCC). and it is the sixth most common primary malignancy overall. Egypt had …
carcinoma (HCC). and it is the sixth most common primary malignancy overall. Egypt had …
Chronic hepatitis C and its outcomes: liver cirrhosis, hepatocellular carcinoma
VV Makashova, KG Omarova… - Epidemiology and …, 2023 - journals.eco-vector.com
The literature review is devoted to the course of chronic hepatitis C (CHC), describes new
treatments with direct-acting antivirals and their efficacy. The outcomes of CHC, such as liver …
treatments with direct-acting antivirals and their efficacy. The outcomes of CHC, such as liver …